Piper Sandler analyst Clarke Jeffries maintains Amplitude (NASDAQ:AMPL) with a Overweight and lowers the price target from $25 to $21.
JP Morgan Maintains Overweight on Immunocore Hldgs, Raises Price Target to $67
JP Morgan analyst Jessica Fye maintains Immunocore Hldgs (NASDAQ:IMCR) with a Overweight and raises the price target from $60 to $67.